Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials

Jing Wang, Li Yu, Kefeng Li
doi: https://doi.org/10.1101/2020.04.13.20064295
Jing Wang
1Department of Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, China
2Division of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, University of California, San Diego, CA, 92037, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Yu
3Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China
4Moores Cancer Center, School of Medicine, University of California, San Diego, CA, 92037, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kefeng Li
5Department of Medicine, School of Medicine, University of California, San Diego, CA, 92037, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kli{at}ucsd.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2020.04.13.20064295
History 
  • April 18, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Jing Wang1,2,
  2. Li Yu3,4 and
  3. Kefeng Li5,*
  1. 1Department of Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, China
  2. 2Division of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, University of California, San Diego, CA, 92037, United States
  3. 3Department of Clinical Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China
  4. 4Moores Cancer Center, School of Medicine, University of California, San Diego, CA, 92037, United States
  5. 5Department of Medicine, School of Medicine, University of California, San Diego, CA, 92037, United States
  1. ↵*Corresponding author: kli{at}ucsd.edu
Back to top
PreviousNext
Posted April 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
Jing Wang, Li Yu, Kefeng Li
medRxiv 2020.04.13.20064295; doi: https://doi.org/10.1101/2020.04.13.20064295
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
Jing Wang, Li Yu, Kefeng Li
medRxiv 2020.04.13.20064295; doi: https://doi.org/10.1101/2020.04.13.20064295

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Therapeutics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)